Announcements Trials
Browse Landscape

Phase

Phase NA 10Phase 2 4Phase 4 3Phase 3 3Phase 1/2 3Phase 2/3 2

Status

Completed 7Unknown 3Recruiting 3Terminated 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Pain, Postoperative 1Pain 1Neuralgia 1

Interventions

Cisplatin 130Radiotherapy 94Carboplatin 85Paclitaxel 78Fluorouracil 78Cyclophosphamide 77Gemcitabine 72Capecitabine 66Docetaxel 65Doxorubicin 60Oxaliplatin 59Etoposide 57Leucovorin 49Vincristine 47Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Neoadjuvant Therapy 28Pemetrexed 27Tamoxifen 25Prednisone 24Irinotecan 24Rituximab 21Methotrexate 21Radiotherapy, Intensity-Modulated 19apatinib 18Vinorelbine 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Bupivacaine × Clear all
NCT03304444 2017-10-09

A Comparison of Exparel to Bupivacaine in TAP Block for Abdominal Gynecologic Surgery

Abington Memorial Hospital

Phase 3 Unknown
128 enrolled

Pain, Postoperative

NCT02336529 2015-10-27

Nerveblocks for Persistent Pain After Breast Cancer Surgery

Rigshospitalet, Denmark

Phase 3 Unknown
48 enrolled
Breast

Breast Neoplasms, Neuralgia, Pain

NCT01314144 2011-03-14

Use of Continuous Wound Infusion of Bupivacaine for Analgesia Following Axillary Clearance Surgery

Cork University Hospital

Phase 3 Unknown
42 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡